Literature DB >> 25696089

C-reactive protein as a pro-inflammatory mediator in cardiovascular disease by its ability to activate complement: additional proof and hypothetical mechanisms.

W K Lagrand, R Nijmeijer, H W M Niessen, C A Visser, W Th Hermens, C E Hack.   

Abstract

This study was financially supported by the Netherlands Heart Foundation, grant numbers 93-119 and 97-088. Dr. Niessen is a recipient of the Dr. E. Dekker programme of the Netherlands Heart Foundation (D99025).

Entities:  

Keywords:  C-reactive protein; inflammation; inflammatory mediators; myocardial infarction; myocardial ischaemia

Year:  2002        PMID： 25696089      PMCID： PMC2499743     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


  38 in total

1.  Role for complement as an intermediate between C-reactive protein and intercellular adhesion molecule-1 expression?

Authors:  W K Lagrand; H W Niessen; R Nijmeijer; C E Hack
Journal:  Circulation       Date:  2001-08-28       Impact factor: 29.690

Review 2.  Therapeutic inhibition of the complement system.

Authors:  S C Makrides
Journal:  Pharmacol Rev       Date:  1998-03       Impact factor: 25.468

Review 3.  A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells.

Authors:  C E Hack; G J Wolbink; C Schalkwijk; H Speijer; W T Hermens; H van den Bosch
Journal:  Immunol Today       Date:  1997-03

4.  Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response.

Authors:  R M Crowl; T J Stoller; R R Conroy; C R Stoner
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

5.  Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells.

Authors:  O Fourcade; M F Simon; C Viodé; N Rugani; F Leballe; A Ragab; B Fournié; L Sarda; H Chap
Journal:  Cell       Date:  1995-03-24       Impact factor: 41.582

6.  Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.

Authors:  P R Maroko; C B Carpenter; M Chiariello; M C Fishbein; P Radvany; J D Knostman; S L Hale
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

7.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

Authors:  M A DeWood; J Spores; R Notske; L T Mouser; R Burroughs; M S Golden; H T Lang
Journal:  N Engl J Med       Date:  1980-10-16       Impact factor: 91.245

8.  Quantitative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardium.

Authors:  F Hugo; T Hamdoch; D Mathey; H Schäfer; S Bhakdi
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

9.  Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain.

Authors:  H Jiang; F A Robey; H Gewurz
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

10.  Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions.

Authors:  I KUSHNER; M H KAPLAN
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.